Anticorps Polyclonaux Purifiés par Affinité à l’Antigène

Anti-Human Exodus-2 (CCL21)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P109
Description:
Anti-Human Exodus-2 (CCL21)
 

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hExodus-2. Anti-Human Exodus-2 specific antibody was purified by affinity chromatography employing immobilized hExodus-2 matrix.

Immunogen: E.coli derived Recombinant Human Exodus-2 (CCL21) (PeproTech catalog# 300-35). *Catalog# 300-35 has been discontinued.

Sandwich ELISA: To detect hExodus-2 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human Exodus-2 (500-P109Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hExodus-2.

Anti-Human Exodus-2 (CCL21) Sandwich ELISA

Western Blot: To detect hExodus-2 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hExodus-2 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human Exodus-2 (CCL21) Western Blot Reduced Anti-Human Exodus-2 (CCL21) Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Steiniger, B
Title
The three-dimensional structure of human splenic white pulp compartments.
Citation
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society; 51(5) pg655-64
PubMed Id
First Author
Kriehuber, E
Title
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.
Citation
The Journal of Experimental Medicine; 194(6) pg797-808
PubMed Id